RPCEC00000149已完成4 期
Evaluation of the safety and effectiveness of ior EPOCIM® in the management of anemia of the preterm infant.
Center of Molecular Immunology(CIM)0 个研究点目标入组 121 人开始时间: 2013年2月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 121
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 16 days 至 /A (No limit)（—）
- 性别
- All
入选标准
- •1.Preterm patients with weight = 1500 g and gestational age < 34 weeks (determined by the method of date of last menstruation. 2.Patients whose parent or responsible family member has granted your consent to participation in the study in writing.
- •3.Patients with more than 15 days old.
- •4.Patients with an intake of at least 50 mL/kg/day of maternal and/or artificial milk.
排除标准
- •1.Patients with diagnosis of hemorrhagic or hemolytic disease.
- •2.Patients with a diagnosis of major congenital malformation requiring transfer to another service of Neonatology.
研究者
相似试验
招募中
不适用
Evaluation of safety and effectiveness regarding intraocular cyclophotocoagulation for refractory glaucomaRefractory terminal glaucoma Glaucoma absolutumJPRN-UMIN000027090Sato Yuya Eye Clinic20
已完成
2 期
Assessment of the Results of Inovo Sense Smile and Inovo Sense Style Filler Injections to Correction Nasolabial FoldsIRCT20220723055530N1Khosro Medisa Teb Company30
已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementiaRPCEC00000410Center of Molecular Immunology (CIM)1,456
进行中（未招募）
Unknown
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75